[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
TG Therapeutics, Inc. (TGTX)
TG Therapeutics faces scrutiny over missed EPS despite strong revenue growth for Briumvi. Social media buzz highlights concerns over competitor drug news and potential undervaluation.
About TG Therapeutics, Inc.
TG Therapeutics, Inc. is a biopharmaceutical company focused on treatments for B-cell malignancies and autoimmune diseases.
TG Therapeutics, Inc. uses the ticker $TGTX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- TG Therapeutics, Inc. (TGTX) trading volume is up XXXX% from the previous week.
- TG Therapeutics, Inc. (TGTX) social dominance is up XXXXXX% from the previous month.
- TG Therapeutics, Inc. (TGTX) creators is up XXXXX% from the previous week.
- TG Therapeutics, Inc. (TGTX) mentions is up XXXX% from the previous week.
- TG Therapeutics, Inc. (TGTX) posts created is up XXXXX% from the previous week.
Price: $XX
Price 24-Hour Time-Series Raw Data
The current price action is a reaction to a mixed earnings report where strong revenue growth and raised guidance for Briumvi were weighed against a missed EPS target. Social posts indicate a significant drop following news of competitor drug results, with some analysts suggesting the stock is undervalued.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%
1-Year High: $XXXXX on 2025-04-30
1-Year Low: $XXXXX on 2025-08-11
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
TG Therapeutics, Inc. (TGTX) is currently AltRank #639 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX -XXX
X Month: XXX -XX
X Months: XXX -XXX
X Year: XXX +553
1-Year High: XXXXX on 2025-07-28
1-Year Low: XX on 2025-02-16
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX +3
X Year: XX +21
1-Year High: XX on 2025-03-14
1-Year Low: XX on 2025-12-09
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX +22%
1-Year High: XXXXXXX on 2025-05-05
1-Year Low: XXX on 2025-12-07
Engagements by network (24h): Reddit: XX X: XXXXXX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX +38%
X Month: XXX -XX%
X Months: XXXXX +1.50%
X Year: XXXXXX +33%
1-Year High: XXX on 2025-08-13
1-Year Low: XX on 2025-10-24
Mentions by network (24h): Reddit: X X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning TG Therapeutics, Inc. (TGTX) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX +47%
X Month: XXX +9.10%
X Months: XXXXX +33%
X Year: XXXXX +58%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-10-22
The most influential creators that mention TG Therapeutics, Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @semodough | X | XXXXXX | X | XXXXX |
| @zipjet | X | XXXXX | XX | XXXXX |
| @Lucy3370 | X | XXXXX | XX | XXXXX |
| @TroyTiger | X | XXX | X | XXX |
| @uchi_wawa | X | XXX | X | XXX |
| @unnatural78 | X | XXX | X | XXX |
| @BehroozNajafi | X | XX | X | XXX |
| @MattBiotech | X | XXXXX | X | XXX |
| @BuyTheUgly | X | XX | X | XX |
| @Chat3Free | XX | XXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-11-18
1-Year Low: XX% on 2025-10-05
Most Supportive Themes:
- Briumvi Patient Retention: (35%) Positive data regarding Briumvi's patient retention rates, exceeding expectations and aligning with industry benchmarks.
- Azer-cel Car-T Therapy: (25%) Positive developments and data related to the Azer-cel Car-T therapy, indicating progress in its development and potential.
- Analyst Optimism: (15%) Analysts express positive sentiment towards TG Therapeutics, with buy ratings and increased price targets reflecting confidence in the company's future.
Most Critical Themes:
- EPS Miss: (10%) The company missed analyst expectations for Earnings Per Share (EPS) in the recent quarter, raising concerns about profitability despite revenue growth.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.015%
X Month: XXXXX% +0.047%
X Months: XXXXX% +0.043%
X Year: XXXXX% -XXXXXX%
1-Year High: XXXXX% on 2024-12-26
1-Year Low: XXXXXX% on 2025-10-24
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-04-07
1-Year Low: XXXXXXX% on 2025-08-11
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$0.95%
X Month: $XXXXXXXXXXXXX +$1.70%
X Months: $XXXXXXXXXXXXX -$12%
X Year: $XXXXXXXXXXXXX +$1.90%
1-Year High: $XXXXXXXXXXXXX on 2025-04-30
1-Year Low: $XXXXXXXXXXXXX on 2025-08-11
Top TG Therapeutics, Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$FSR $NNE $TGTX To Analyst price target for next week-"
X Link @Chat3Free 2025-12-11T19:28Z XXX followers, XX engagements
"$CISS $NNE $TGTX To Analyst price target for next week-"
X Link @Chat3Free 2025-12-11T19:21Z XXX followers, XXX engagements
"The markets loud but sentiment speaks louder. December 11ths analysis reveals where conviction is climbingand where cautions taking over $CV $CRBP $PL $NDSN $IPW $DXYZ $OXM $POM $MTN $TGTX $TE $CBRL $ORCL $ROKU $GME $ASTS $ADBE $NFLX $WBD #FinTwit #StockMarket #MarketSentiment"
X Link @ContextAnalytic 2025-12-11T14:19Z 1982 followers, XXX engagements
"$TGTX quarterly revenues are growing at QoQ. Q4 estimates are thus 2026 breakdown is: Q1 $200M Q2 $220M Q3 $240M Q4 Total 2026 that's base case. We can see upside to is not out of the question"
X Link @thegunnerab 2025-12-11T14:18Z 5012 followers, XXX engagements